Sepracor, Alza deal

SEPR (Marlborough, Mass.) reached an agreement in principle with AZA (Palo Alto) to provide the single isomer form of a drug in a transdermal delivery system. The drug, whose identity will not be revealed pending a definitive agreement, is already marketed as a racemic mixture.

AZA will have worldwide rights to market the drug. SEPR will receive undisclosed development costs and royalty payments. ...